TY - JOUR AU - Bendell, J. C. AU - Domchek, S. M. AU - Burstein, H. J. AU - Harris, L. AU - Younger, J. AU - Kuter, I. PY - 2003 DA - 2003// TI - Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11436 DO - 10.1002/cncr.11436 ID - Bendell2003 ER - TY - JOUR AU - Lin, N. U. AU - Bellon, J. R. AU - Winer, E. P. PY - 2004 DA - 2004// TI - CNS metastases in breast cancer JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.01.175 DO - 10.1200/JCO.2004.01.175 ID - Lin2004 ER - TY - JOUR AU - Tsukada, Y. AU - Fouad, A. AU - Pickren, J. W. AU - Lane, W. W. PY - 1983 DA - 1983// TI - Central nervous system metastasis from breast carcinoma. Autopsy study JO - Cancer VL - 52 UR - https://doi.org/3.0.CO;2-B DO - 3.0.CO;2-B ID - Tsukada1983 ER - TY - JOUR AU - Patanaphan, V. AU - Salazar, O. M. AU - Risco, R. PY - 1988 DA - 1988// TI - Breast cancer: metastatic patterns and their prognosis JO - South Med J VL - 81 UR - https://doi.org/10.1097/00007611-198809000-00011 DO - 10.1097/00007611-198809000-00011 ID - Patanaphan1988 ER - TY - JOUR AU - Heitz, F. AU - Harter, P. AU - Lueck, H. -. J. AU - Fissler-Eckhoff, A. AU - Lorenz-Salehi, F. AU - Scheil-Bertram, S. PY - 2009 DA - 2009// TI - Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2009.06.027 DO - 10.1016/j.ejca.2009.06.027 ID - Heitz2009 ER - TY - JOUR AU - Lagerwaard, F. J. AU - Levendag, P. C. AU - Nowak, P. J. AU - Eijkenboom, W. M. AU - Hanssens, P. E. AU - Schmitz, P. I. PY - 1999 DA - 1999// TI - Identification of prognostic factors in patients with brain metastases: a review of 1292 patients JO - Int J Radiat Oncol Biol Phys VL - 43 UR - https://doi.org/10.1016/S0360-3016(98)00442-8 DO - 10.1016/S0360-3016(98)00442-8 ID - Lagerwaard1999 ER - TY - JOUR AU - Ranjan, T. AU - Abrey, L. E. PY - 2009 DA - 2009// TI - Current management of metastatic brain disease JO - Neurotherapeutics VL - 6 UR - https://doi.org/10.1016/j.nurt.2009.04.012 DO - 10.1016/j.nurt.2009.04.012 ID - Ranjan2009 ER - TY - JOUR AU - Lassman, A. B. AU - Abrey, L. E. AU - Shah, G. D. AU - Shah, G. G. AU - Panageas, K. S. AU - Begemann, M. PY - 2006 DA - 2006// TI - Systemic high-dose intravenous methotrexate for central nervous system metastases JO - J Neuro-Oncol VL - 78 UR - https://doi.org/10.1007/s11060-005-9044-6 DO - 10.1007/s11060-005-9044-6 ID - Lassman2006 ER - TY - JOUR AU - Glantz, M. J. AU - Cole, B. F. AU - Recht, L. AU - Akerley, W. AU - Mills, P. AU - Saris, S. PY - 1998 DA - 1998// TI - High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary? JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.4.1561 DO - 10.1200/JCO.1998.16.4.1561 ID - Glantz1998 ER - TY - JOUR AU - Eisenhauer, E. A. AU - Therasse, P. AU - Bogaerts, J. AU - Schwartz, L. H. AU - Sargent, D. AU - Ford, R. PY - 2009 DA - 2009// TI - New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) JO - Eur J Cancer VL - 45 UR - https://doi.org/10.1016/j.ejca.2008.10.026 DO - 10.1016/j.ejca.2008.10.026 ID - Eisenhauer2009 ER - TY - JOUR AU - Bowman, K. M. AU - Kumthekar, P. PY - 2018 DA - 2018// TI - Medical management of brain metastases and leptomeningeal disease in patients with breast carcinoma JO - Future Oncol VL - 14 UR - https://doi.org/10.2217/fon-2017-0255 DO - 10.2217/fon-2017-0255 ID - Bowman2018 ER - TY - JOUR AU - Cheng, X. AU - Hung, M. -. C. PY - 2007 DA - 2007// TI - Breast cancer brain metastases JO - Cancer Metastasis Rev VL - 26 UR - https://doi.org/10.1007/s10555-007-9083-x DO - 10.1007/s10555-007-9083-x ID - Cheng2007 ER - TY - JOUR AU - Eichler, A. F. AU - Loeffler, J. S. PY - 2007 DA - 2007// TI - Multidisciplinary management of brain metastases JO - Oncologist VL - 12 UR - https://doi.org/10.1634/theoncologist.12-7-884 DO - 10.1634/theoncologist.12-7-884 ID - Eichler2007 ER - TY - JOUR AU - Peacock, K. H. AU - Lesser, G. J. PY - 2006 DA - 2006// TI - Current therapeutic approaches in patients with brain metastases JO - Curr Treat Options in Oncol VL - 7 UR - https://doi.org/10.1007/s11864-006-0023-8 DO - 10.1007/s11864-006-0023-8 ID - Peacock2006 ER - TY - JOUR AU - Lee, Y. -. C. AU - Hsieh, C. -. C. AU - Chuang, J. -. P. AU - Li, C. -. Y. PY - 2017 DA - 2017// TI - The necessity of intrathecal chemotherapy for the treatment of breast cancer patients with leptomeningeal metastasis: a systematic review and pooled analysis JO - Curr Probl Cancer VL - 41 UR - https://doi.org/10.1016/j.currproblcancer.2017.07.001 DO - 10.1016/j.currproblcancer.2017.07.001 ID - Lee2017 ER - TY - JOUR AU - Bartsch, R. AU - Rottenfusser, A. AU - Wenzel, C. AU - Dieckmann, K. AU - Pluschnig, U. AU - Altorjai, G. PY - 2007 DA - 2007// TI - Trastuzumab prolongs overall survival in patients with brain metastases from Her2 positive breast cancer JO - J Neuro-Oncol VL - 85 UR - https://doi.org/10.1007/s11060-007-9420-5 DO - 10.1007/s11060-007-9420-5 ID - Bartsch2007 ER - TY - JOUR AU - Park, Y. H. AU - Park, M. J. AU - Ji, S. H. AU - Yi, S. Y. AU - Lim, D. H. AU - Nam, D. H. PY - 2009 DA - 2009// TI - Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients JO - Br J Cancer VL - 100 UR - https://doi.org/10.1038/sj.bjc.6604941 DO - 10.1038/sj.bjc.6604941 ID - Park2009 ER - TY - JOUR AU - Bartsch, R. AU - Berghoff, A. AU - Pluschnig, U. AU - Bago-Horvath, Z. AU - Dubsky, P. AU - Rottenfusser, A. PY - 2012 DA - 2012// TI - Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases JO - Br J Cancer VL - 106 UR - https://doi.org/10.1038/bjc.2011.531 DO - 10.1038/bjc.2011.531 ID - Bartsch2012 ER - TY - JOUR AU - Lin, N. U. AU - Diéras, V. AU - Paul, D. AU - Lossignol, D. AU - Christodoulou, C. AU - Stemmler, H. -. J. PY - 2009 DA - 2009// TI - Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1080 DO - 10.1158/1078-0432.CCR-08-1080 ID - Lin2009 ER - TY - JOUR AU - Margolin, K. AU - Ernstoff, M. S. AU - Hamid, O. AU - Lawrence, D. AU - McDermott, D. AU - Puzanov, I. PY - 2012 DA - 2012// TI - Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial JO - Lancet Oncol VL - 13 UR - https://doi.org/10.1016/S1470-2045(12)70090-6 DO - 10.1016/S1470-2045(12)70090-6 ID - Margolin2012 ER - TY - JOUR AU - Goldberg, S. B. AU - Gettinger, S. N. AU - Mahajan, A. AU - Chiang, A. C. AU - Herbst, R. S. AU - Sznol, M. PY - 2016 DA - 2016// TI - Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30053-5 DO - 10.1016/S1470-2045(16)30053-5 ID - Goldberg2016 ER - TY - JOUR AU - Bachelot, T. AU - Romieu, G. AU - Campone, M. AU - Diéras, V. AU - Cropet, C. AU - Dalenc, F. PY - 2013 DA - 2013// TI - Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(12)70432-1 DO - 10.1016/S1470-2045(12)70432-1 ID - Bachelot2013 ER -